The Latest News
- June 2013
-
NEW Parabon to Present at AFCEA DC Emerging Technologies Symposium
Reuters
AFCEA DC Selects Parabon to Present at Emerging Technology Symposium
- May 2013
- Parabon Awarded CRCF Grant for Artificial Vaccine Platform PRWEB
CIT Announces Awards for the Commonwealth Research Commercialization Fund (CRCF) FY2013 Solicitation
- January 2013
- Parabon featured in Biotechs Explore Role for 3D Printing In Drug Development
By Christie Rizk — New York Genome Center
- December 2012
- The 7 Best Inventions of 2012 Huffington Post
Huffington Post names Parabon Essemblix one of the seven best inventions of 2012
- Drag-and-Drop DNA National Science Foundation
Novel technique aiding development of new cancer drugs
- 3D Printing Cancer Drugs Molecule-By-Molecule, Using DNA Scaffolds ExtremeTech
By John Hewitt
- Drag-and-Drop Drug Targets Brain Cancer Wired UK
By Duncan Geere
- Parabon NanoLabs Awarded NSF Grant for Development of Cancer Therapeutic with Industry Partner Janssen R&D
Novel formulation aims to reduce side-effects and improve efficacy of approved chemotherapeutic compound
- September 2012
- Dr. Ellen McRae Joins Parabon NanoLabs
Harvard-trained bioinformaticist joins Parabon to tackle big data of genomics
- August 2012
- DNA Origami for Signal Transduction
Parabon NanoLabs and Marshall University demonstrate new structural sensing form
- June 2012
- DTRA SBIR Phase II Award
Parabon NanoLabs to build revolutionary forensic system for the U.S. Department of Defense
- March 2012
- Essemblix-V Artificial Vaccine Platform
Parabon NanoLabs demonstrates its nano-pharmaceutical platform to create artificial vaccines
- Older News